Ames Research Center S.R.L.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials
• Schizophrenia2 trials
• Depression1 trial

Phase

• Phase 23 trials

Status

• Not yet recruiting2 trials
• Recruiting1 trial

Lead sponsor

• MapLight Therapeutics2 trials
• Eli Lilly and Company1 trial

Running trials

• Not yet recruiting

  A Study of Brenipatide in Participants With Major Depressive Disorder

  NCT07928245· Phase 2· Eli Lilly and Company· Source

  Contact: Dan Rosu (principal investigator)

• Enrolling by invitation

  An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

  NCT07459660· Phase 2· MapLight Therapeutics· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  NCT06887192· Phase 2· MapLight Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• Schizophrenia2 recruiting
• Depression1 recruiting